Publicaciones en colaboración con investigadores/as de King's College London (2)

2019

  1. Vemurafenib as first-line therapy in BRAF -V600E-mutant Erdheim-Chester disease with CNS involvement

    BMJ Case Reports, Vol. 12, Núm. 11

2002

  1. Quality of life in patients with schizophrenia in five European countries: The EPSILON study

    Acta Psychiatrica Scandinavica, Vol. 105, Núm. 4, pp. 283-292